MiniMed officer receives new RSU stock awards

MiniMed Group, Inc. reported that officer Ali Dianaty received two equity awards of common stock on July 1, 2026.

Rhea-AI Filing Summary

MiniMed Group, Inc. reported that officer Ali Dianaty received two equity awards of common stock on July 1, 2026. The filing shows grants classified as restricted stock units under the 2026 Long Term Incentive Plan, covering 36,762 shares and 94,550 shares of common stock at no cash cost.

The RSUs tied to these awards vest over time, with one grant vesting in approximately equal one-third increments on the first, second and third anniversaries of the grant date, and another vesting on the third anniversary. Existing holdings also include shares to be issued upon vesting of prior RSUs and 600 shares acquired under the 2026 Employee Stock Purchase Plan.

Insider Trade Summary

Grant/Award: 131,312 shares

Grant/Award 2 txns

Insider Dianaty Ali

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	94,550	$0.00	$0.00
Grant/Award	Common Stock	36,762	$0.00	$0.00

Holdings After Transaction: Common Stock — 323,170 shares (Direct)

Footnotes (4)

1. F1. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date.
2. F2. Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.
3. F3. Includes 600 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026.
4. F4. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the third anniversary of the grant date.

Key Figures

RSU grant 1: 36,762 shares RSU grant 2: 94,550 shares Price per share: $0.00 per share +3 more

6 metrics

RSU grant 1 36,762 shares Restricted stock units granted on July 1, 2026

RSU grant 2 94,550 shares Restricted stock units granted on July 1, 2026

Price per share $0.00 per share Reported transaction price for both RSU grants

Shares after grant line 1 323,170 shares Total common stock following first reported grant

Shares after grant line 2 286,408 shares Total common stock following second reported grant

ESPP acquisition 600 shares Shares acquired under 2026 Employee Stock Purchase Plan on June 30, 2026

Key Terms

restricted stock units ("RSUs"), Long Term Incentive Plan, Employee Stock Purchase Plan, grant of restricted stock units

4 terms

restricted stock units ("RSUs") financial

"Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Long Term Incentive Plan financial

"pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments"

A long term incentive plan is a company program that awards executives and key employees bonuses—often in stock, options, or cash—only if the business meets multi-year performance goals. It links management pay to company results—like tying a coach’s bonus to a team’s multi-season record—so investors monitor it for how leaders are motivated, potential share dilution, and signals about the company’s long-term priorities.

Employee Stock Purchase Plan financial

"Includes 600 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026."

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

grant of restricted stock units financial

"Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the third anniversary"

FAQ

What did MiniMed Group (MMED) report in this Form 4 for Ali Dianaty?

MiniMed Group reported that officer Ali Dianaty received two stock-based awards on July 1, 2026. These are equity compensation grants of restricted stock units under the 2026 Long Term Incentive Plan, increasing his reported holdings in MiniMed common stock.

How many MiniMed Group (MMED) shares were granted to Ali Dianaty?

The Form 4 shows two grants of MiniMed common stock: one for 36,762 shares and another for 94,550 shares. Both are reported as equity awards with a per-share transaction price of $0.00, reflecting compensation rather than an open-market purchase.

What is the vesting schedule for Ali Dianaty’s MiniMed (MMED) RSU grants?

One RSU grant vests in approximately equal one-third increments on the first, second and third anniversaries of the July 1, 2026 grant date. A separate RSU award vests fully on the third anniversary of that grant date, tying value to continued service.

Does the Form 4 show open-market buying or selling of MiniMed (MMED) stock?

The transactions are coded as “A” for awards, indicating grants or other acquisitions, not open‑market trades. The filing does not report any purchases or sales in the market; it reflects stock-based compensation and related share holdings instead.

What other MiniMed (MMED) holdings are disclosed for Ali Dianaty?

The footnotes state that reported holdings include shares to be issued upon vesting of one or more RSUs. They also note 600 shares of common stock acquired under MiniMed’s 2026 Employee Stock Purchase Plan on June 30, 2026, which are part of his reported position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 05:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dianaty Ali

(Last) (First) (Middle)

C/O MINIMED GROUP, INC.

18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CALIFORNIA 91325

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		94,550(1)	A	$0	286,408(2)(3)	D
Common Stock	07/01/2026		A		36,762(4)	A	$0	323,170(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date.

2. Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.

3. Includes 600 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026.

4. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the third anniversary of the grant date.

Remarks:

EVP, Chief Product and Technology Officer

	/s/ Bryan F. Kelly, attorney-in-fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)